Haya Ascher-Svanum, PhD

Letter to the Editor

Overestimating the Prevalence of Subtherapeutic Dosing of Atypical Antipsychotics

August 15, 2009

Michael D. Stensland, Haya Ascher-Svanum, Anthony H. Lawson, et al

Original Research

Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response

June 2, 2009

Jean-Pierre Lindenmayer, Hong Liu-Seifert, Pandurang M. Kulkarni, et al

Original Research

Tardive Dyskinesia and the 3-Year Course of Schizophrenia: Results From a Large, Prospective, Naturalistic Study

October 31, 2008

Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, et al

Original Research

Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder

August 15, 2007

Eduardo Dunayevich, Haya Ascher-Svanum, Fangyi Zhao, et al

Original Research

The 3-Year Clinical and Functional Course of Schizophrenia Among Individuals With and Without Diabetes at Study Entry

April 16, 2007

Haya Ascher-Svanum, Baojin Zhu, Frank R. Ernst, et al

Original Research

A Prospective Study of Risk Factors for Nonadherence With Antipsychotic Medication in the Treatment of Schizophrenia

July 14, 2006

Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, et al

Original Research

Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care

March 15, 2006

Haya Ascher-Svanum, Douglas E. Faries, Baojin Zhu, et al

Overestimating the Prevalence of Subtherapeutic Dosing of Atypical Antipsychotics

Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response

Tardive Dyskinesia and the 3-Year Course of Schizophrenia: Results From a Large, Prospective, Naturalistic Study

Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder

The 3-Year Clinical and Functional Course of Schizophrenia Among Individuals With and Without Diabetes at Study Entry

A Prospective Study of Risk Factors for Nonadherence With Antipsychotic Medication in the Treatment of Schizophrenia

Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care

ELSEWHERE:

FOLLOW US:

Haya Ascher-Svanum, PhD

Overestimating the Prevalence of Subtherapeutic Dosing of Atypical Antipsychotics

Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response

Tardive Dyskinesia and the 3-Year Course of Schizophrenia: Results From a Large, Prospective, Naturalistic Study

Longer Time to Antipsychotic Treatment Discontinuation for Any Cause Is Associated With Better Functional Outcomes for Patients With Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder

The 3-Year Clinical and Functional Course of Schizophrenia Among Individuals With and Without Diabetes at Study Entry

A Prospective Study of Risk Factors for Nonadherence With Antipsychotic Medication in the Treatment of Schizophrenia

Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles